Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc. (NTHI) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NTHI · as of Jun 8, 2026
Activity summary
Buy transactions
21
P-Purchase only
Sell transactions
10
12 Months
Buy/Sell ratio
2.10
Buy/Sell (by trades)
Overall sentiment
Neonc Technologies Holdings, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
NTHI insider buying and selling by quarter
NTHI insider selling · NTHI insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · NTHI ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NTHI executive sell shares · NTHI board member insider trading · NTHI insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 24, 2025 | Heshmatpour Amir F President · Director | Purchase | 6,000 | $39K | Form 4 |
| Nov 21, 2025 | Heshmatpour Amir F President · Director | Purchase | 4,000 | $26K | Form 4 |
| Nov 20, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Purchase | 1,100 | $7K | Form 4 |
| Jun 5, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Award | 133,000 | — | Form 4 |
| Jun 5, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Award | 67,000 | — | Form 4 |
| May 22, 2025 | CHEN THOMAS C CEO · Director | Purchase | 2,709 | $20K | Form 4 |
| May 21, 2025 | CHEN THOMAS C CEO · Director | Purchase | 2,759 | $20K | Form 4 |
| May 22, 2025 | GARNETT KEITHLY CFO | Purchase | 675 | $5K | Form 4 |
| May 19, 2025 | GARNETT KEITHLY CFO | Purchase | 135 | $976 | Form 4 |
| May 12, 2025 | Delshad Jim Director | Purchase | 5,000 | $36K | Form 4 |
| Apr 17, 2025 | Delshad Jim Director | Purchase | 50 | $346 | Form 4 |
| Mar 26, 2025 | Delshad Jim Director | Purchase | 50 | $802 | Form 4 |
| May 13, 2025 | GARNETT KEITHLY CFO | Purchase | 90 | $631 | Form 4 |
| May 12, 2025 | CHEN THOMAS C CEO · Director | Purchase | 400 | $3K | Form 4 |
| May 15, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,500 | $11K | Form 4 |
| May 14, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,000 | $7K | Form 4 |
| May 13, 2025 | Heshmatpour Amir F President · Director | Purchase | 990 | $7K | Form 4 |
| May 12, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,400 | $10K | Form 4 |
| May 11, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,600 | $12K | Form 4 |
| Mar 26, 2025 | Delshad Jim Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | GARNETT KEITHLY CFO · Director | Other | 687 | — | Form 4 |
| Mar 26, 2025 | GIANNOTTA STEVEN L. Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | CHIANG MING-FU (ALAN) Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | CHIANG MING-FU (ALAN) Director | Other | 5,994 | — | Form 4 |
| Mar 26, 2025 | Heshmatpour Amir F Director | Other | 3,996 | — | Form 4 |
Heshmatpour Amir F
President · Director
Date
Nov 24
Shares
6,000
Price
$6.51
Value
$39K
Heshmatpour Amir F
President · Director
Date
Nov 21
Shares
4,000
Price
$6.50
Value
$26K
Neman-Ebrahim Yousha
Chief Clinical Officer
Date
Nov 20
Shares
1,100
Price
$6.69
Value
$7K
Neman-Ebrahim Yousha
Chief Clinical Officer
Date
Jun 5
Shares
133,000
Price
—
Value
—
Neman-Ebrahim Yousha
Chief Clinical Officer
Date
Jun 5
Shares
67,000
Price
—
Value
—
Heshmatpour Amir F
President · Director
Date
May 15
Shares
1,500
Price
$7.30
Value
$11K
Heshmatpour Amir F
President · Director
Date
May 14
Shares
1,000
Price
$7.27
Value
$7K
Heshmatpour Amir F
President · Director
Date
May 13
Shares
990
Price
$7.01
Value
$7K
Heshmatpour Amir F
President · Director
Date
May 12
Shares
1,400
Price
$7.23
Value
$10K
Heshmatpour Amir F
President · Director
Date
May 11
Shares
1,600
Price
$7.51
Value
$12K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NTHI insider trading
NTHI insider trades
Neonc Technologies Holdings, Inc. (NTHI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Heshmatpour Amir F (President · Director), Neman-Ebrahim Yousha (Chief Clinical Officer). Over the past 12 months, 2 insiders have filed transactions with the SEC. NTHI insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Neonc Technologies Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NTHI insider trading · 5 questionsThe insiders of Neonc Technologies Holdings, Inc. (NTHI) include executives and directors such as Heshmatpour Amir F (President · Director), Neman-Ebrahim Yousha (Chief Clinical Officer), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026